CNS Pharmaceuticals Operating Expenses 2011-2026 | CNSP

Annual Operating Expenses CNS Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
14.9 M	18.9 M	15.3 M	14.5 M	9.45 M	3.83 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
18.9 M	3.83 M	12.8 M

Quarterly Operating Expenses CNS Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
3.25 M	2.41 M	4.34 M	-	5.63 M	2.53 M	3.54 M	-	4.53 M	4.03 M	4.93 M	-	3.42 M	3.56 M	3.15 M	-	3.81 M	3.81 M	3.61 M	-	2.01 M	2.47 M	1.97 M	-	699 K	415 K	195 K	-	170 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.63 M	170 K	2.93 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Regeneron Pharmaceuticals REGN	4.87 B	$ 742.1	-1.93 %	$ 77.6 B	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
AbbVie ABBV	12.8 B	$ 211.9	0.37 %	$ 375 B	USA
Replimune Group REPL	262 M	$ 7.26	-3.71 %	$ 585 M	USA
AbCellera Biologics ABCL	292 M	$ 3.28	-2.24 %	$ 980 M	Canada
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Rigel Pharmaceuticals RIGL	127 M	$ 26.28	-0.34 %	$ 473 M	USA
Aileron Therapeutics ALRN	50.6 M	-	10.36 %	$ 9.8 M	USA
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	427 M	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
Avenue Therapeutics ATXI	5.21 K	-	-52.27 %	$ 4.45 M	USA
Avidity Biosciences RNA	765 M	$ 13.07	-0.23 %	$ 1.8 B	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Atreca BCEL	98.7 M	-	-11.76 %	$ 5.79 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	854 M	-	-	$ 546 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
Rhythm Pharmaceuticals RYTM	146 M	$ 77.56	-5.31 %	$ 5.04 B	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Avid Bioservices CDMO	26 M	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	141 M	$ 12.27	-12.11 %	$ 1.86 B	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
SIGA Technologies SIGA	14 M	$ 5.36	7.96 %	$ 383 M	USA
Silence Therapeutics plc SLN	2.66 M	$ 4.92	-7.34 %	$ 622 M	Britain
SELLAS Life Sciences Group SLS	-18.9 K	$ 4.47	-9.69 %	$ 487 M	USA
BioDelivery Sciences International BDSI	106 M	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	142 M	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	120 M	-	-	$ 3.74 B	USA
Enlivex Therapeutics Ltd. ENLV	19.3 M	$ 1.08	-1.38 %	$ 22.2 M	Israel
Enochian Biosciences ENOB	189 M	-	-	$ 40.5 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Summit Therapeutics SMMT	1.09 B	$ 16.59	-3.88 %	$ 12.4 B	Britain
Spruce Biosciences SPRB	36.5 M	$ 62.07	-10.19 %	$ 47.6 M	USA